Stock 1762 CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Equities

1762

TW0001762003

Pharmaceuticals

End-of-day quote Taiwan S.E.
Other stock markets
 18:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
46 TWD -0.65% Intraday chart for Chunghwa Chemical Synthesis & Biotech Co., Ltd. +2.45% -19.86%
03-28 Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-11 Chunghwa Chemical Synthesis & Biotech Co., Ltd. cancelled the transaction announced on March 11, 2024 CI

Business Summary

CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of biotechnology products and chemical synthetic products. The Company's biotechnology products include pravastatin, rapamycin, tacrolimus, everolimus, mycophenolate mofetil, mycophenolic acid sodium and others. Its non-biotechnology products include methocarbamol, guaifenesin, trandolapril, fluconazole, olopatadine, dexbromopheniramine maleate and glipizide, among others. Its products are applied in the manufacture of drugs for treatment of cough, diabetes, cardiovascular diseases, high blood pressure and immune system diseases. The Company distributes its products within domestic market and to overseas markets, including the rest of Asia, the Americas and Europe.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Non-biotech
63.3 %
1,069 50.5 % 1,320 63.3 % +23.48%
Biotechnology
36.7 %
1,041 49.2 % 765 36.7 % -26.55%
Labor
0.1 %
6 0.3 % 1 0.1 % -81.39%

Sales per region

TWD in Million2022Weight2023Weight Delta
United States
68.0 %
1,441 68.1 % 1,418 68.0 % -1.60%
India
9.5 %
229 10.8 % 197 9.5 % -13.69%
Ireland
8.2 %
50 2.3 % 172 8.2 % +245.81%
Others
6.7 %
148 7.0 % 140 6.7 % -4.86%
Japan
5.5 %
173 8.2 % 115 5.5 % -33.60%
Taiwan
2.1 %
77 3.6 % 44 2.1 % -43.19%

Managers

Managers TitleAgeSince
Chung Hsin Huang CEO
 Chief Executive Officer - 09-12-28
Chun-Ming Chen CTO
 Chief Tech/Sci/R&D Officer - 17-02-12
Kuan-Chieh Wang IRO
 Public Communications Contact - -
Hsiu Fen Lin AUD
 Comptroller/Controller/Auditor - 17-05-21
Kuo Hsien Tseng PRN
 Corporate Officer/Principal - 87-06-30

Members of the board

Members of the board TitleAgeSince
Yin Nan Sun BRD
 Director/Board Member - 98-05-11
Cheng Hsien Tsai BRD
 Director/Board Member - 12-06-19
Chung Hsin Huang CEO
 Chief Executive Officer - 09-12-28
Kuo Chiang Wang BRD
 Director/Board Member - 10-06-07
Chih Hsien Chang BRD
 Director/Board Member - 16-05-30
Hou Jie Wang BRD
 Director/Board Member - 20-01-16
Yi-Zhen Xie Wang CHM
 Chairman - 20-11-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 77,560,000 45,827,000 ( 59.09 %) 0 59.09 %

Shareholders

NameEquities%Valuation
RAM Active Investments SA
0.4519 %
350,526 0.4519 % 535 043 NT$
Yuanta Securities Investment Trust Co., Ltd.
0.0786 %
61,000 0.0786 % 93 110 NT$
Dimensional Fund Advisors Ltd.
0.0739 %
57,337 0.0739 % 87 519 NT$
DFA Australia Ltd.
0.003749 %
2,908 0.003749 % 4 439 NT$

Company contact information

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

No. 1 Dongxing Street Shu-Lin District

238 50, New Taipei

+

http://www.ccsb.com.tw
address Chunghwa Chemical Synthesis & Biotech Co., Ltd.(1762)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
46 TWD
Average target price
48 TWD
Spread / Average Target
+4.35%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. Stock Chunghwa Chemical Synthesis & Biotech Co., Ltd.
-19.86% 111M
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.45% 40.51B
BIOGEN INC. Stock Biogen Inc.
-15.94% 31.67B
UCB Stock UCB
+52.66% 24.62B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-14.50% 15.65B
INCYTE CORPORATION Stock Incyte Corporation
-14.38% 12.07B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.12% 11.97B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.56% 11.61B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.87% 8.81B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-4.33% 8.5B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 1762 Stock
  4. Company Chunghwa Chemical Synthesis & Biotech Co., Ltd.